Nasdaq · CIK 0001014739
OPCH Option Care Health, Inc.
Insider trading from SEC Form 4. Last filing May 19, 2025. Close $31.07 on Oct 9, 2026, +59% from the 52-week low and -15% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
13
with a Form 4 at this company
Price and insider trades, last year
OPCHOct 9, 2026 · close 31.07
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Option Care Health, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | Michael Bavaro Chief Human Resources Officer sell | $1.0M 30,996 shares | -41% | - | |
| 43Moderate | Harry M Jansen Kraemer Jr director buy | $969k 43,000 shares | +15% | - |
Congressional trades
4 trades in OPCH disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Trade | Asset | Reported range | Trade / filing date | Source |
|---|---|---|---|---|---|
Lisa C. McClain House · R-MI | Sale | OPCH Option Care Health, Inc. - Common Stock | $1,001 to $15k | Oct 30, 2025 / Nov 21, 2025 22 days after the trade | Clerk |
Lisa C. McClain House · R-MI | Purchase | OPCH Option Care Health, Inc. - Common Stock | $1,001 to $15k | Oct 30, 2025 / Nov 21, 2025 22 days after the trade | Clerk |
Lisa C. McClain House · R-MI | Sale | OPCH Option Care Health, Inc. - Common Stock | $1,001 to $15k | Oct 31, 2025 / Nov 21, 2025 21 days after the trade | Clerk |
Lisa C. McClain House · R-MI | Purchase | OPCH Option Care Health, Inc. - Common Stock | $1,001 to $15k | Sep 25, 2025 / Oct 22, 2025 27 days after the trade | Clerk |
Transactions
The last 40 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 14, 2025 | Eric Brandt director | AGrant or award Common Stock | +5,034 | $0.00 | $0 | 10,359 | May 19, 2025 |
| May 14, 2025 | Elizabeth D Bierbower director | AGrant or award Common Stock | +5,034 | $0.00 | $0 | 23,874 | May 19, 2025 |
| May 14, 2025 | Barbara W. Bodem director | AGrant or award Common Stock | +5,034 | $0.00 | $0 | 12,090 | May 19, 2025 |
| May 14, 2025 | Natasha Deckmann director | AGrant or award Common Stock | +5,034 | $0.00 | $0 | 21,534 | May 19, 2025 |
| May 14, 2025 | Elizabeth Quadros Betten director | AGrant or award Common Stock | +5,034 | $0.00 | $0 | 26,373 | May 19, 2025 |
| May 14, 2025 | Natasha Deckmann director | AGrant or award Common Stock | +627 | $31.79 | $20k | 22,161 | May 19, 2025 |
| Apr 22, 2025 | Femi Adewunmi Chief Medical Officer | FTax withholding Common Stock | -1,396 | $31.54 | $44k | 18,758 | Apr 24, 2025 |
| Feb 28, 2025 | Michael Bavaro Chief Human Resources Officer | MOption exercise Common Stock | +1,226 | $18.97 | $23k | 62,457 | Mar 3, 2025 |
| Feb 28, 2025 | Michael Bavaro Chief Human Resources Officer | MOption exercise Common Stock | +8,974 | $25.75 | $231k | 71,431 | Mar 3, 2025 |
| Feb 28, 2025 | Michael Bavaro Chief Human Resources Officer | MOption exercise Common Stock | +2,153 | $23.96 | $52k | 73,584 | Mar 3, 2025 |
| Feb 28, 2025 | Michael Bavaro Chief Human Resources Officer | MOption exercise Common Stock | +2,386 | $28.86 | $69k | 75,970 | Mar 3, 2025 |
| Feb 28, 2025 | Michael Bavaro Chief Human Resources Officer | SOpen-market sale Common Stock | -30,996 | $33.26 | $1.0M | 44,974 | Mar 3, 2025 |
| Feb 28, 2025 | Michael Bavaro Chief Human Resources Officer | MOption exercise Employee Stock Option (right to buy)derivative | -1,226 | $0.00 | $0 | 0 | Mar 3, 2025 |
| Feb 28, 2025 | Michael Bavaro Chief Human Resources Officer | MOption exercise Employee Stock Option (right to buy)derivative | -8,974 | $0.00 | $0 | 0 | Mar 3, 2025 |
| Feb 28, 2025 | Michael Bavaro Chief Human Resources Officer | MOption exercise Employee Stock Option (right to buy)derivative | -2,153 | $0.00 | $0 | 2,153 | Mar 3, 2025 |
| Feb 28, 2025 | Michael Bavaro Chief Human Resources Officer | MOption exercise Employee Stock Option (right to buy)derivative | -2,386 | $0.00 | $0 | 4,772 | Mar 3, 2025 |
| Feb 24, 2025 | Femi Adewunmi Chief Medical Officer | AGrant or award Common Stock | +10,287 | $0.00 | $0 | 20,154 | Feb 26, 2025 |
| Feb 24, 2025 | Michael Bavaro Chief Human Resources Officer | AGrant or award Common Stock | +10,599 | $0.00 | $0 | 61,231 | Feb 26, 2025 |
| Feb 24, 2025 | Christopher L. Grashoff Chief Growth Officer | AGrant or award Common Stock | +13,404 | $0.00 | $0 | 36,139 | Feb 26, 2025 |
| Feb 20, 2025 | Christopher L. Grashoff Chief Growth Officer | FTax withholding Common Stock | -1,677 | $32.39 | $54k | 23,464 | Feb 24, 2025 |
| Feb 20, 2025 | Michael Bavaro Chief Human Resources Officer | FTax withholding Common Stock | -1,019 | $32.39 | $33k | 51,453 | Feb 24, 2025 |
| Feb 22, 2025 | Michael Bavaro Chief Human Resources Officer | FTax withholding Common Stock | -554 | $32.00 | $18k | 50,899 | Feb 24, 2025 |
| Feb 22, 2025 | Christopher L. Grashoff Chief Growth Officer | FTax withholding Common Stock | -462 | $32.00 | $15k | 23,002 | Feb 24, 2025 |
| Feb 23, 2025 | Christopher L. Grashoff Chief Growth Officer | FTax withholding Common Stock | -267 | $32.00 | $8,544 | 22,735 | Feb 24, 2025 |
| Feb 23, 2025 | Michael Bavaro Chief Human Resources Officer | FTax withholding Common Stock | -267 | $32.00 | $8,544 | 50,632 | Feb 24, 2025 |
| Feb 17, 2025 | Michael Bavaro Chief Human Resources Officer | FTax withholding Common Stock | -473 | $31.46 | $15k | 42,044 | Feb 19, 2025 |
| Feb 17, 2025 | Christopher L. Grashoff Chief Growth Officer | FTax withholding Common Stock | -223 | $31.46 | $7,016 | 25,141 | Feb 19, 2025 |
| Feb 17, 2025 | Michael Bavaro Chief Human Resources Officer | FTax withholding Common Stock | -6,791 | $31.46 | $214k | 35,253 | Feb 19, 2025 |
| Feb 18, 2025 | Michael Bavaro Chief Human Resources Officer | AGrant or award Common Stock | +17,219 | $0.00 | $0 | 52,472 | Feb 19, 2025 |
| Nov 8, 2024 | Harry M Jansen Kraemer Jr director | POpen-market purchase Common Stock | +43,000 | $22.54 | $969k | 326,334 | Nov 13, 2024 |
| Oct 26, 2024 | John Charles Rademacher Chief Executive Officer | MOption exercise Common Stock | +31,216 | $0.00 | $0 | 627,615 | Oct 29, 2024 |
| Oct 26, 2024 | John Charles Rademacher Chief Executive Officer | FTax withholding Common Stock | -13,829 | $29.45 | $407k | 613,786 | Oct 29, 2024 |
| Oct 26, 2024 | John Charles Rademacher Chief Executive Officer | MOption exercise Restricted Stock Unitderivative | -31,216 | $0.00 | $0 | 0 | Oct 29, 2024 |
| Oct 21, 2024 | Michael Bavaro Chief Human Resources Officer | FTax withholding Common Stock | -911 | $30.51 | $28k | 42,517 | Oct 23, 2024 |
| Oct 21, 2024 | Christopher L. Grashoff Chief Growth Officer | FTax withholding Common Stock | -911 | $30.51 | $28k | 25,364 | Oct 23, 2024 |
| Oct 21, 2024 | Nicole Maggio Chief Accounting Officer | FTax withholding Common Stock | -342 | $30.51 | $10k | 14,717 | Oct 23, 2024 |
| Oct 21, 2024 | Michael H. Shapiro Chief Financial Officer | MOption exercise Common Stock | +17,088 | $0.00 | $0 | 264,405 | Oct 23, 2024 |
| Oct 21, 2024 | Luke Whitworth Chief Operating Officer | FTax withholding Common Stock | -3,785 | $30.51 | $115k | 114,095 | Oct 23, 2024 |
| Oct 21, 2024 | Michael H. Shapiro Chief Financial Officer | FTax withholding Common Stock | -7,570 | $30.51 | $231k | 256,835 | Oct 23, 2024 |
| Oct 21, 2024 | Michael H. Shapiro Chief Financial Officer | MOption exercise Restricted Stock Unitderivative | -17,088 | $0.00 | $0 | 0 | Oct 23, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Femi AdewunmiChief Medical Officer
- Elizabeth Quadros Bettendirector
- Eric Brandtdirector
- Michael BavaroChief Human Resources Officer
- Elizabeth D Bierbowerdirector
- Barbara W. Bodemdirector
- Natasha Deckmanndirector
- Christopher L. GrashoffChief Growth Officer
- Harry M Jansen Kraemer Jrdirector
- Nicole MaggioChief Accounting Officer
- John Charles RademacherChief Executive Officer
- Michael H. ShapiroChief Financial Officer
- Luke WhitworthChief Operating Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.